---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-019831"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T08:44:18.330542+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Chief Business Officer Ahmed Mousa resigns to become CEO of Vicore Pharma

## Summary
- Ahmed Mousa to resign as SVP, Chief Business Officer, General Counsel & Corporate Secretary effective September 11, 2023.
- Resignation to become CEO of Vicore Pharma Holding AB; no disagreement with Pieris on any matter.
- CEO Stephen Yoder will oversee corporate and business development following Mousa's departure.
- Mousa expected to serve as strategic advisor for a transition period subject to mutual terms.

## SEC filing metadata
- accession: 0001437749-23-019831
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774923019831/0001437749-23-019831-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774923019831/pirs20230705c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-019831
- JSON: https://secwatch.observer/filing/0001437749-23-019831.json
- Plain text: https://secwatch.observer/filing/0001437749-23-019831.txt

## Key facts
- Executive change
  Ahmed Mousa resigned as Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary at PALVELLA THERAPEUTICS, INC..
  - Action: resigned
  - Role: Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary
  source text: On July 13, 2023, Ahmed Mousa, the Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary of Pieris Pharmaceuticals, Inc. (the “Company”), gave notice that he will resign from the Company effective September 11, 2023 in order to become chief executive officer of Vicore Pharma Holding AB.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583648/000143774923019831/0001437749-23-019831-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.